Long-term dupilumab reduces exacerbations and improves lung function in type 2 patients with/without allergic asthma
Autor: | Sher, L. 1, ⁎, Corren, J. 2, Pavord, I. 3, Floquet, S. 4, ⁎, Pandit-Abid, N. 5, Radwan, A. 6, Jacob-Nara, J. 5, Deniz, Y. 6, Rowe, P. 5 |
---|---|
Zdroj: | In Revue Française d'Allergologie April 2023 63(3) |
Databáze: | ScienceDirect |
Externí odkaz: |